Suven Pharmaceuticals Ltd - 543064 - Shareholding for the Period Ended June 30, 2020
Suven Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here18-07-2020
18-07-2020
Suven Pharmaceuticals Ltd - 543064 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions on a consolidated basis and balances for the year ended 31st March, 2020.14-07-2020
Suven Pharmaceuticals Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, please find enclosed herewith the Confirmation Certificate issued by KFin Technologies Private Limited, Registrar and Share Transfer Agents of the Company, for the quarter ended June 30, 2020.07-07-2020
Suven Pharmaceuticals Ltd - 543064 - Closure of Trading Window
We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st July, 2020 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter ending 30th June, 2020, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.30-06-2020
Suven Pharmaceuticals Ltd - 543064 - Compliances-Reg.24(A)-Annual Secretarial Compliance
With reference to above subject, please find enclosed herewith the Annual Secretarial Compliance Report for the year ended 31st March, 2020, issued by Practicing Company Secretary, under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019.25-06-2020
Suven Pharmaceuticals Ltd - 543064 - Large Corporate -Initial Confirmation
With reference to above subject, we enclosed herewith confirmation for the financial year ended 31 March, 2020 in the prescribed format, under the SEBI Circular SEBI/HO/DDHS/CIR/P/2018/ 144 dated November 26, 2018.25-06-2020
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement regarding to Financial Results of the Company19-06-2020
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached Investor Communication18-06-2020
Suven Pharmaceuticals Ltd - 543064 - Audited Standalone And Consolidated Financial Results Under Ind AS For The Quarter And For The Financial Year Ended 31St March, 2020
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. June 18, 2020, has taken on record and approved the Audited Standalone and Consolidated Financial Results of the Company under Ind AS for the quarter and for the year ended 31st March, 2020 and approved the following matters.18-06-2020
Suven Pharmaceuticals Ltd - 543064 - Outcome Of Board Meeting
The Board of Directors of the company, at its meeting held today i.e. June 18, 2020, has taken on record and approved the Audited Standalone and Consolidated Financial Results of the Company under Ind AS for the quarter and for the year ended 31st March, 2020 and approved the following matters.18-06-2020